Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

By Bryan L. Roth, K. Baner, R. Westkaemper, D. Siebert, K. Rice, SeAnna Steinberg, P. Ernsberger, R. Rothman. Proceedings of the National Academy of Sciences of the United States of America, 2002

711 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/4a8e5395c873ef5bc8ff62815f72ec28cd8e7db1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. Bryan L. Roth
2. Brian K. Shoichet
3. M. Krashes
4. S. Waddell

In Molecular Biology

1. Bryan L. Roth
2. Brian K. Shoichet
3. John J. Irwin
4. Jianyang Zeng
5. Mehmet Gönen
6. Kyle Swanson
7. Vijay S. Pande
8. Brian K. Kobilka

Citations in the corpus

• A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior (2015, background): “Since SALB is an inactive, drug-like metabolite of the KOR selective agonist salvinorin A (SALA) (Ansonoff et al., 2006; Roth et al., 2002), and because SALB has excellent CNS penetrability and pharmacokinetic properties in both rodents and non-human primates (Hooker et al., 2009), the SALB/KORD…”
• Relating protein pharmacology by ligand chemistry (2007, methodology): “Radioligand and functional assays were performed as previously detailed using the resources of the National Institute of Mental Health's Psychoactive Drug Screening Progra”